Fertility and Sterility
Volume 94, Issue 5 , Pages 1578-1582 , October 2010

Ethinylestradiol and estradiol have different effects on oxidative stress and nitric oxide synthesis in human endothelial cell cultures

  • Mayra Beraldo Andozia, B.M.Sc.

      Affiliations

    • Department of Gynecology and Obstetrics, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil
    • ,
  • Carolina Sales Vieira, M.D., Ph.D.

      Affiliations

    • Department of Gynecology and Obstetrics, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil
    • National Institute of Hormones and Women's Health, Ribeirão Preto, Brazil
    • Corresponding Author InformationReprint requests: Carolina Sales Vieira, M.D., Ph.D., Av. Bandeirantes 3900, Campus Universitário, Departamento de Ginecologia e Obstetrícia da Faculdade de Medicina de Ribeirão Preto/USP, CEP: 14049-900, Ribeirão Preto–SP, Brazil (FAX: +55 16 3633-0946).
    • ,
  • Silvio Antônio Franceschini, M.D.

      Affiliations

    • Department of Gynecology and Obstetrics, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil
    • ,
  • Maria Regina Torqueti Tolloi, Ph.D.

      Affiliations

    • Faculty of Pharmacy of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil
    • ,
  • Marcos Felipe Silva de Sá, M.D., Ph.D.

      Affiliations

    • Department of Gynecology and Obstetrics, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil
    • National Institute of Hormones and Women's Health, Ribeirão Preto, Brazil
    • ,
  • Rui Alberto Ferriani, M.D., Ph.D.

      Affiliations

    • Department of Gynecology and Obstetrics, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil
    • National Institute of Hormones and Women's Health, Ribeirão Preto, Brazil

Received 9 June 2009 ,Revised 17 August 2009 ,Accepted 19 August 2009.

References 

  1. World Health Organization. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group. World Health Org Tech Rep Ser. 1998;877:i–89
  2. World Health Organization. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet. 1995;346:1575–1582
  3. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol. 2002;22:201–210
  4. Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y, et al. Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke. 2002;33:1202–1208
  5. Khader YS, Rice J, John L, Abueita O. Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception. 2003;68:11–17
  6. Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab. 2005;90:3863–3870
  7. Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J Thromb Haemost. 2003;1:1371–1380
  8. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983–1992
  9. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev. 2008;60:210–241
  10. Dubey RK, Tofovic SP, Jackson EK. Cardiovascular Pharmacology of Estradiol Metabolites. J Pharmacol Exp Ther. 2003;308:403–409
  11. Lobo RA, Stanczyk FZ. New knowledge in the physiology of hormonal contraceptives. Am J Obstet Gynecol. 1994;170:1499–1507
  12. Lizarelli PM, Martins WP, Vieira CS, Soares GM, Franceschini SA, Ferriani RA, et al. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women. Contraception. 2009;79:35–40
  13. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation. 1997;96:2795–2801
  14. de Kleijn MJ, Wilmink HW, Bots ML, Bak AA, van der Schouw YT, Planellas J, et al. Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women. Atherosclerosis. 2001;159:357–365
  15. Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation. 1998;98:1158–1163
  16. Terlinden R, Uragg H, Göhler K, Kneip C. Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate. Contraception. 2006;74:239–244
  17. Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab 2007; 92:3060–3067.
  18. Takahashi S, Abe T, Gotoh J, Fukuuchi Y. Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons. Neurochem Int. 2002;40:441–448
  19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth. 1983;65:55–63
  20. Wang Y-K, Huang Z- Q. Protective effects of icariin on human umbilical vein endothelial cell injury induced by H2O2 in vitro. Pharmacol Res. 2005;52:174–182
  21. Kojima H, Nakatsubo N, Kikuchi K, Urano Y, Higuchi T, Tanaka J, et al. Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA. Neuroreport. 1998;26:3345–3348
  22. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, et al. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem. 1998;70:2446–2453
  23. Nakatsubo N, Kojima H, Kikuchi K, Nagoshi H, Hirata Y, Maeda D, et al. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Lett. 1998;427:263–266
  24. Bolego C, Cignarella A, Ruzza R, Zaarour C, Messi E, Zanisi M, et al. Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats. Life Sci. 1997;60:2291–2302
  25. Merki-Feld GS, Imthurn B, Keller PJ. The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels. Horm Metab Res. 2000;32:288–293
  26. John S, Jacobi J, Schlaich M, Delles C, Schmieder RE. Effects of oral contraceptives on vascular endothelium in premenopausal women. Am J Obstet Gynaecol. 2000;183:28–33
  27. Bednarek-Tupikowska G, Tworowska-Bardzinska U, Tupikowski K. Effects of estrogen and estrogen-progesteron on serum nitric oxide metabolite concentrations in post-menopausal women. J Endocrinol Invest. 2008;31:877–81.
  28. Oishi A, Ohmichi M, Takahashi K, Takahashi T, Mori-Abe A, Kawagoe J, et al. Medroxyprogesterone acetate attenuates estrogen-induced nitric oxide production in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2004;324:193–198
  29. Caulin-Glaser T, García-Cardeña G, Sarrel P, Sessa WC, Bender JR. 17 beta-Estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ Res. 1997;81:885–892
  30. Kharitonov SA, Logan-Sinclair RB, Busset CM, Shinebourne EA. Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J. 1994;72:243–245
  31. Williams MR, Westerman RA, Kingwell BA, Paige J, Blombery PA, Sudhir K, et al. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab. 2001;86:5389–5395
  32. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Genazzani AR. Genomic and nongenomic effects of estrogens on endothelial cells. Steroids. 2004;69:537–542
  33. Eich RF, Li T, Lemon DD, Doherty DH, Curry SR, Aitken JF, et al. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry. 1996;35:6976–6983
  34. Yang F, Troncy E, Francoeur M, Vinet B, Vinay P, Czaika G, et al. Effects of reducing reagents and temperature on conversion of nitrite and nitrate to nitric oxide and detection of NO by chemiluminescence. Clin Chem. 1997;43:657–662
  35. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem. 1982;126:131–138
  36. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen reduces angiotensin II–induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23:38–44
  37. Yen CH, Hsieh CC, Chou SY, Lau YT. 17 b-Estradiol inhibits oxidized low density lipoprotein-induced generation of reactive oxygen species in endothelial cells. Life Sci. 2001;70:403–413
  38. Bednarek-Tupikowska G, Tworowska U, Jedrychowska I, Radomska B, Tupikowski K, Bidzinska-Speichert B, et al. Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in posmenopausal women. Clin Endocrinol. 2006;64:463–468
  39. Dantas AP, Tostes RCA, Fortes ZB, Costa SG, Nigro D, Carvalho MH. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension. 2002;39:405–411
  40. Pincemail J, Vanbelle S, Gaspard U, Collette G, Haleng J, Cheramy-Bien JP, et al. Effect of different contraceptive methods on the oxidative stress status in women aged 40–48 years from the ELAN study in the province of Liege, Belgium. Hum Reprod. 2007;22:2335–2343
  41. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Förstermann U. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension. 1998;31:582–588
  42. Arnal JF, Clamens S, Pechet C, Negre-Salvayre A, Allera C, Girolami JP, et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci U S A. 1996;93:4108–4113

 M.B.A. has nothing to disclose. C.S.V. has nothing to disclose. S.A.F. has nothing to disclose. M.R.T.T. has nothing to disclose. M.F.S.d.S. has nothing to disclose. R.A.F. has nothing to disclose.

 Supported by the Sector of Human Reproduction, Department of Gynecology and Obstetrics, Ribeirão Preto School of Medicine, University of São Paulo, Brazil, and from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, National Council for Scientific and Technological Development).

PII: S0015-0282(09)03590-0

doi: 10.1016/j.fertnstert.2009.08.052

Fertility and Sterility
Volume 94, Issue 5 , Pages 1578-1582 , October 2010

Article Tools

* Image Usage & Resolution